These lines of evidence demonstrated that miR-31 in hBMSC-EVs inhibited the expression of NFAT5 in NPCs, thereby accelerating NPC proliferation and inhibiting NPC apoptosis and ECM degradation. This evidence concerns the gene NFAT5 and nasopharyngeal carcinoma.